1. Home
  2. ORIC vs IART Comparison

ORIC vs IART Comparison

Compare ORIC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.87

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$13.93

Market Cap

823.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIC
IART
Founded
2014
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
837.3M
823.8M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ORIC
IART
Price
$8.87
$13.93
Analyst Decision
Strong Buy
Hold
Analyst Count
13
7
Target Price
$19.73
$14.33
AVG Volume (30 Days)
1.4M
954.1K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
19.67
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.39
Revenue Next Year
N/A
$3.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.65
$8.70
52 Week High
$14.93
$16.42

Technical Indicators

Market Signals
Indicator
ORIC
IART
Relative Strength Index (RSI) 36.43 72.93
Support Level $7.90 $12.90
Resistance Level $11.22 $14.38
Average True Range (ATR) 0.55 0.71
MACD -0.09 0.37
Stochastic Oscillator 6.47 89.60

Price Performance

Historical Comparison
ORIC
IART

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: